Table 1.
Analysis of combined ER and PgR status of the 37 cases of intraductal breast cancer.
| Hormone Receptor status | Number of patients | Percentage |
|---|---|---|
| ER− & PgR− | 21 | 56.7% |
| ER+ & PgR+ | 11 | 29.7% |
| ER+ & PgR− | 2 | 5.4% |
| ER− & PgR+ | 3 | 8.1% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.